BDCRB

CAT: 0804-HY-19296Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-19296Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

BDCRB is a selective Human cytomegalovirus (HCMV) inhibitor through blocking the maturational cleavage of high-molecular-weight DNA. BDCRB shows a mean IC50 of 0.03 μM for viral yield at 72 h postinfection[1].

CAS Number

142356-43-2

Product Name Alternative

2-Bromo-5,6-dichloro-1-β-D-ribofuranosyl benzimidazole

UNSPSC

12352005

Target

CMV

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/bdcrb.html

Solubility

10 mM in DMSO

Smiles

O[C@H]1[C@H](N2C3=CC(Cl)=C(Cl)C=C3N=C2Br)O[C@H](CO)[C@H]1O

Molecular Formula

C12H11BrCl2N2O4

Molecular Weight

398.04

References & Citations

[1]Biron KK, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob Agents Chemother. 2002 Aug;46 (8) :2365-72.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Alternative Products

Catalog	Name
BUP07284-01	BDCRB

BDCRB

Alternative Products

Popular Products